Management of liver tumors from metastatic colorectal cancer (mCRC) presents a complex challenge to oncologists and multidisciplinary treatment teams.
Selective internal radiation therapy (SIRT) with SIR-Spheres® Y-90 resin microspheres is an approved local therapy for the management of unresectable mCRC liver tumors with proven evidence and ongoing clinical research:
- Over 100,000 doses have been administered in more than 1,300 medical centers worldwide.
- In addition, recent data from an array of large, multi-center, international studies support expanded use of SIR-Spheres Y-90 resin microspheres in appropriate patients.
- Sirtex is supporting a clinical research program to further investigate and expand the use of SIR-Spheres Y-90 resin microspheres.